Toggle navigation
Home
Medical
FDA Approves First Gene Therapy for Beta-Thalassemia
17-8-2022
Medical
https://www.medscape.com/cx/rssfeeds/2700.xml
102
Betibeglogene autotemcel represents a potential cure for patients with beta-thalassemia, but the price tag is $2.1 million. FDA Approvals
Share
Tweet
+1
Read The Rest
at : https://www.medscape.com/cx/rssfeeds/2700.xml
Related News
In Small Study, CAR-T Therapy Pushes Lupus Into Remission
FDA Approves Botox Competitor That Lasts Longer
Azerbaijan Thalassemia Center and BGI partner to improve...
New discovery means diagnosis and support for people with...
Researchers identify new disorder of copper metabolism,...
Hormone Replacement Therapy shown to be highly effective...
A randomized multi-center study on the effectiveness of...
Stable, Long-term Opioid Therapy Safer Than Tapering?
STAT+: ‘We’re finally here’: Harvard graduate spearheads...
STAT+: Pharmalittle: FDA approves a gene therapy for a...